The association between EZH2 and circadian genes, including CLOCK and BMAL1, could shed light on the molecular mechanisms that drive HCC progression and underscore the significance of circadian regulation in cancer biology. The gene discussed is BMAL1; the disease is hepatocellular carcinoma.